After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q1 2017 call → NO我们根据提供的财报电话会议记录来判断。管理层是否报告了最重要的积极发展发生在报告期结束或之后,以至于结果几乎没有包含这些影响,并且管理层自己指出了这一时机? 分析内容: - 会议讨论了SPINRAZA的销售(第一季度超过4700万美元),这是商业收入,但这是整个季度的销售,没有特别强调是季末或之后发生的。 - 提到了Bayer的7500万美元付款,用于推进IONIS-FXIRx和IONIS-FXI-LRx,这笔付款在Q1收到,并确认了大部分收入,但这是季度内的事件,没有强调是季末。 - Novartis合作(价值16亿美元)在1月宣布,收到1.75亿美元,这也是季度内的事件。 - volanesorsen的III期数据在3月公布,也是季度内。 - 关键点:SPINRAZA的CHMP积极意见是在4月底(即季度结束后)收到的,但这是关于欧盟批准,尚未转化为销售。管理层提到“At the end of April, Biogen received a positive CHMP opinion”,但这是预期未来批准,不是已经发生的业务。 - 管理层没有明确说“这些事件发生在季末或之后,所以本季度结果没有反映它们”。相反,他们讨论了本季度的财务业绩,并展望未来。 - 关于SPINRAZA销售,他们提到“first quarter sales of over $47 million”,这是整个季度的,没有强调是季末。 - 关于IONIS-TTRRx数据,计划在本季度(Q2)报告,但尚未发生。 - 管理层没有将任何具体事件标记为“late-breaking”并说结果没有包含其影响。 因此,没有证据表明管理层强调了季末或之后发生的具体积极事件,并说这些事件是结果未反映的。他们只是正常报告了季度业绩和未来计划。 答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...